Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Grant-Huerta Yanina
Chief Accounting Officer at Atara Biotherapeutics. Filing since 16 May 2025.
CIK 0002064348
Company
Date
Role
Action
Shares
Amount
Of holding
ATRA
Atara Biotherapeutics, Inc.
18 May 2026
Chief Accounting Officer
Sold at will
2,414
$22.04K
4.6%
ATRA
Atara Biotherapeutics, Inc.
2 Mar 2026
Chief Accounting Officer
Sold at will
2,104
$10.69K
6.2%
ATRA
Atara Biotherapeutics, Inc.
17 Nov 2025
Chief Accounting Officer
Sold at will
1,804
$23.79K
5.1%
ATRA
Atara Biotherapeutics, Inc.
18 Aug 2025
Chief Accounting Officer
Sold at will
1,809
$21.01K
4.9%
ATRA
Atara Biotherapeutics, Inc.
16 May 2025
Chief Accounting Officer
Sold at will
2,218
$15.00K
5.6%
5 decisions on file.
